Skip to content

CAPRICOR THERAPEUTICS, INC.: 10-K filed 2013-06-21

What CAPRICOR THERAPEUTICS, INC. reported in its annual report filed 2013-06-21 (fiscal FY 2012): 34 published measures, 98 facts as tagged in accession 0001144204-13-036076.

This filing

Form
10-K (annual report)
Filed
2013-06-21
Fiscal period
fiscal FY 2012
Accession
0001144204-13-036076 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CAPRICOR THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-12-31227,054USD
At 2011-12-311,372,170USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-12-31394,367USD
At 2011-12-31541,447USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-12-31-167,313USD
At 2011-12-31830,723USD
At 2010-12-312,596,868USD
At 2009-12-312,982,150USD
At 2008-12-315,103,618USD
At 2007-12-3115,199,932USD
At 2006-12-31-2,576,515USD
At 2005-12-31-5,043USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-12-3146,716USD
At 2011-12-311,039,190USD
At 2010-12-313,378,155USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-1,893,037USD366
2005-08-01 to 2012-12-31-46,708,017USD2710
2011-01-01 to 2011-12-31-4,884,786USD365
2010-01-01 to 2010-12-31-6,031,491USD365
2009-01-01 to 2009-12-31-7,872,297USD365
2008-01-01 to 2008-12-31-13,131,596USD366
2007-01-01 to 2007-12-31-10,302,795USD365
2006-01-01 to 2006-12-31-2,581,972USD365
2005-08-01 to 2005-12-31-10,043USD153

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-2,186,681USD366
2005-08-01 to 2012-12-31-34,891,160USD2710
2011-01-01 to 2011-12-31-4,649,292USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-01-01 to 2012-12-310USD366
2005-08-01 to 2012-12-31130,855USD2710
2011-01-01 to 2011-12-311,987USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2012-01-01 to 2012-12-31195,500USD366
2005-08-01 to 2012-12-312,032,235USD2710
2011-01-01 to 2011-12-311,354,500USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-01-01 to 2012-12-311,194,207USD366
2005-08-01 to 2012-12-3135,411,822USD2710
2011-01-01 to 2011-12-312,312,314USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-01-01 to 2012-12-310USD366
2005-08-01 to 2012-12-31-473,946USD2710
2011-01-01 to 2011-12-31-1,987USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-12-31-46,708,017USD
At 2011-12-31-44,814,980USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2012-01-01 to 2012-12-310USD366

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-12-313,488USD
At 2011-12-319,744USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-01-01 to 2012-12-31312,690USD366
2005-08-01 to 2012-12-3110,618,150USD2710
2011-01-01 to 2011-12-31806,327USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-2,440,140USD366
2005-08-01 to 2012-12-31-46,925,456USD2710
2011-01-01 to 2011-12-31-4,899,180USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-12-31171,628USD
At 2011-12-311,310,488USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-01-01 to 2012-12-310USD366
2005-08-01 to 2012-12-311,273,734USD2710
2011-01-01 to 2011-12-310USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-12-31330,983USD
At 2011-12-31541,447USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-12-31182,916USD
At 2011-12-31437,837USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-01-01 to 2012-12-312,635,640USD366
2005-08-01 to 2012-12-3148,957,691USD2710
2011-01-01 to 2011-12-316,253,680USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-01-01 to 2012-12-311,023,929USD366
2005-08-01 to 2012-12-3131,019,820USD2710
2011-01-01 to 2011-12-314,136,951USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-12-3143,062,231shares
At 2011-12-3139,712,231shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-12-3146,497,642USD
At 2011-12-3145,605,991USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2012-12-3150,355USD
At 2011-12-3150,355USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-12-3146,867USD
At 2011-12-3140,611USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2012-12-31124,912USD
At 2011-12-31271,298USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2012-12-3116,348,179USD
At 2011-12-3117,344,561USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-01-01 to 2012-12-311,611,711USD366
2005-08-01 to 2012-12-3117,937,871USD2710
2011-01-01 to 2011-12-312,116,729USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2012-01-01 to 2012-12-316,256USD366
2005-08-01 to 2012-12-3175,217USD2710
2011-01-01 to 2011-12-317,507USD365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2012-01-01 to 2012-12-316,256USD366
2005-08-01 to 2012-12-31326,904USD2710
2011-01-01 to 2011-12-317,507USD365

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2012-01-01 to 2012-12-31545,876USD366
2005-08-01 to 2012-12-31695,981USD2710
2011-01-01 to 2011-12-318,388USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2012-01-01 to 2012-12-31547,103USD366
2005-08-01 to 2012-12-31217,439USD2710
2011-01-01 to 2011-12-3114,394USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2012-01-01 to 2012-12-310USD366
2005-08-01 to 2012-12-315,000USD2710
2011-01-01 to 2011-12-310USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-254,921USD366
2005-08-01 to 2012-12-31182,916USD2710
2011-01-01 to 2011-12-31105,457USD365

Inspect the source

Entity
CAPRICOR THERAPEUTICS, INC. / CIK 0001133869
Captured
2026-09-20T07:41:24.575Z
SEC response SHA-256
b9f947143784aa2a5b7cc0470638338f21bd5664475f1be49c554014f98dbf5c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001133869.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))